Skip to main content

Table 1 Characteristics of patients receiving COVID-19 convalescent plasma at time of transfusiona

From: Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest

Characteristic All patients
(N = 31)
Sex – no. (%)
 Female 10 (32)
 Male 21 (68)
BMI 37.4 ± 10.5
Classification of COVID-19 Illness – no. (%)
 Severe 16 (52)
 Life-threatening 15 (48)
Respiratory support at time of transfusion – no. (%)
None 2 (6)
 Low-flow nasal cannula 11 (35)
 High-flow nasal cannula 8 (26)
 Mechanical ventilation 10 (32)
Sequential Organ Failure Assessment (SOFA) Score 2 [4]
C-reactive protein – mg/dL 15.5 ± 9.5
D-dimer – mcg/mL 2.6 ± 4.0
Ferritin – ng/mL 1532 ± 1414
Hospital length of stay in days 12 [22]
Days from CP transfusion to discharge 7 [14]
Final disposition – no. (%)
 Home 15 (48%)
 Inpatient rehabilitation then home 2 (7%)
 Skilled nursing facility or long-term care 5 (5%)
 Dead 4 (13%)
 Ongoing inpatient care 5 (16%)
  1. aPlus-minus values are means ± SD, values with brackets are medians [interquartile range]